CN101537121B - Chinese medicine for treating arteriosclerosis - Google Patents
Chinese medicine for treating arteriosclerosis Download PDFInfo
- Publication number
- CN101537121B CN101537121B CN2008101021902A CN200810102190A CN101537121B CN 101537121 B CN101537121 B CN 101537121B CN 2008101021902 A CN2008101021902 A CN 2008101021902A CN 200810102190 A CN200810102190 A CN 200810102190A CN 101537121 B CN101537121 B CN 101537121B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- fine powder
- radix
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the field of Chinese medicines for treating heart diseases, and provides a Chinese medicine for treating arteriosclerosis with the aims of good healing efficacy and quick response. The Chinese medicine is prepared by fruit of glossy privet, radix paeoniae alba, angelica, herba ecliptae, uncaria, glossy ganoderma, polygonatum, panax pseudoginseng and other Chinese medicines. The Chinese medicine has the functions of reinforcing the body and consolidating foundation, invigorating vital energy and nourishing blood, and promoting blood circulation by removing blood stasis, has good effect and quick response, and has the advantages of good effect and precise healing efficacy.
Description
Technical field
The invention belongs to the cardiopathic field of Chinese medicines of treatment.
Background technology
Existingly be used for the treatment of arteriosclerotic Chinese medicine, there are distinct issues: be exactly that therapeutic effect is obvious inadequately, so that many arteriosclerotics wish to take good care of treatment for a long time with Chinese medicine, and can not find definite effect, Chinese medicine evident in efficacy, have dissatisfied more this patient.
At problem set forth above, the invention provides the arteriosclerotic Chinese medicine of a kind of treatment, it can solve in the past this type of Chinese medicine effect tangible problem inadequately, have effect better, the advantage of determined curative effect.
Summary of the invention
The present invention is achieved through the following technical solutions:
The arteriosclerotic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Fructus Ligustri Lucidi 0.3-2.6 part Radix Paeoniae Alba 0.4-3.2 part Radix Angelicae Sinensis 0.3-2.6 part
Herba Ecliptae 0.3-2.6 part Ramulus Uncariae Cum Uncis 0.3-2.6 part Ganoderma 0.15-1 part
Rhizoma Polygonati Odorati 0.3-2.6 part Radix Notoginseng 0.3-2.6 part
The arteriosclerotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Fructus Ligustri Lucidi, the Radix Paeoniae Alba, Radix Angelicae Sinensis, Herba Ecliptae, an ancient unit of weight rattan, Rhizoma Polygonati Odorati are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks, arteriosclerosis is good at nervous, cardiopalmus of phase, gas is tight, pauses the movable rhythm of the heart and promptly increases to about 120 times/minute dizziness and blurred vision, it is not good enough to sleep, and extremity are numb, and myocardial ischemia belongs to hyperactivity of YANG due to deficiency of YIN, damp and hot numbness resistance is controlled and is worked as nourishing YIN for suppressing the hyperactive YANG, nourishing blood and promoting blood circulation, blood circulation promoting and blood stasis dispelling.We Ganoderma QI invigorating, the body resistance strengthening and constitution consolidating, strongly invigorating primordial QI; Fructus Ligustri Lucidi, Herba Ecliptae, Rhizoma Polygonati Odorati nourish the dirty the moon of conscience kidney three, the Radix Paeoniae Alba, Ramulus Uncariae Cum Uncis suppressing the hyperactive liver and subsiding YANG; Radix Notoginseng, Radix Angelicae Sinensis blood circulation promoting and blood stasis dispelling, blood vessels work.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, nourishing blood and promoting blood circulation, and the merit of blood circulation promoting and blood stasis dispelling, effective, instant effect, it is better to have effect, the advantage of determined curative effect.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Fructus Ligustri Lucidi 55 gram Radix Paeoniae Albas 65 gram Radix Angelicae Sinensis 55 grams
Herba Ecliptae 55 gram Ramulus Uncariae Cum Uncis 40 kairine sesames 25 grams
Rhizoma Polygonati Odorati 45 gram Radix Notoginseng 45 grams
Weight in accordance with regulations, with conventional water extraction process Fructus Ligustri Lucidi, the Radix Paeoniae Alba, Radix Angelicae Sinensis, Herba Ecliptae, an ancient unit of weight rattan, Rhizoma Polygonati Odorati are extracted, make extractum fine powder 110 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 642 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Fructus Ligustri Lucidi 130 gram Radix Paeoniae Albas 200 gram Radix Angelicae Sinensis 160 grams
Herba Ecliptae 160 gram Ramulus Uncariae Cum Uncis 120 kairine sesames 70 grams
Rhizoma Polygonati Odorati 160 gram Radix Notoginseng 150 grams
By above-mentioned same method, make 1948 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Fructus Ligustri Lucidi 260 gram Radix Paeoniae Albas 320 gram Radix Angelicae Sinensis 260 grams
Herba Ecliptae 260 gram Ramulus Uncariae Cum Uncis 260 kairine sesames 100 grams
Rhizoma Polygonati Odorati 260 gram Radix Notoginseng 260 grams
By above-mentioned same method, make 3310 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5.5 parts of 6.5 parts of Radix Angelicae Sinensis of 5 portions of Radix Paeoniae Albas of Fructus Ligustri Lucidi
3.5 parts of 5.5 portions of Ganodermas of 5.2 parts of Ramulus Uncariae Cum Uncis of Herba Ecliptae
5.6 parts of 5.6 portions of Radix Notoginseng of Rhizoma Polygonati Odorati
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
26 parts of 28 parts of Radix Angelicae Sinensis of 25 portions of Radix Paeoniae Albas of Fructus Ligustri Lucidi
9 parts of 24 portions of Ganodermas of 24 parts of Ramulus Uncariae Cum Uncis of Herba Ecliptae
25 parts of 25 portions of Radix Notoginseng of Rhizoma Polygonati Odorati
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science arteriosclerosis, through 24 routine clinical observations.Selecting tcm diagnosis arteriosclerosis is standard: have a delicate constitution, asthenia is unable, and nervous, cardiopalmus, gas are tight, pause activity, and the rhythm of the heart promptly increases to about 120 times/minute, dizziness and blurred vision, and it is not good enough to sleep, and extremity are numb, myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 14 examples, women's 10 examples do not have other serious disease, and the age is 37 years old-77 years old, 54.6 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, nervous, cardiopalmus, gas are tight, tachycardia, and numb limbs and tense tendons, myocardial ischemia, it is not good enough to sleep etc., and symptom is obviously alleviated.
2, effective: body constitution strengthens, and nervous, cardiopalmus, gas are tight, and symptoms such as numbness are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.24 philtrums of clinical experiment, produce effects 11 people, effective 10 people, invalid 3 people, total effective rate 87.5%.
Claims (1)
1. treat arteriosclerotic Chinese medicine for one kind, it is characterized in that: it is to make with the component of following weight ratio:
Fructus Ligustri Lucidi 0.3---2.6 parts of 2.6 portions of Radix Paeoniae Albas 0.4---3.2 parts of Radix Angelicae Sinensis 0.3---
Herba Ecliptae 0.3---1 part of 2.6 parts of Ramulus Uncariae Cum Uncis 0.3---2.6 portions of Ganodermas 0.15---
2.6 parts of Rhizoma Polygonati Odorati 0.3---2.6 portions of Radix Notoginseng 0.3---
The arteriosclerotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Fructus Ligustri Lucidi, the Radix Paeoniae Alba, Radix Angelicae Sinensis, Herba Ecliptae, Ramulus Uncariae Cum Uncis, Rhizoma Polygonati Odorati are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101021902A CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101021902A CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101537121A CN101537121A (en) | 2009-09-23 |
| CN101537121B true CN101537121B (en) | 2011-04-27 |
Family
ID=41120662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101021902A Expired - Fee Related CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101537121B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101850015B (en) * | 2009-09-25 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating arteriosclerosis |
| CN103239583B (en) * | 2013-05-13 | 2015-06-17 | 周柳池 | Airuike heart-soothing granule |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413601A (en) * | 2001-10-22 | 2003-04-30 | 孟宪茹 | Chinese medicine for compound circulation treatment of angiocardiopathy and cerebrovascular disease |
| CN1586544A (en) * | 2004-07-14 | 2005-03-02 | 张国强 | Medicinal wine and its producing method |
-
2008
- 2008-03-19 CN CN2008101021902A patent/CN101537121B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413601A (en) * | 2001-10-22 | 2003-04-30 | 孟宪茹 | Chinese medicine for compound circulation treatment of angiocardiopathy and cerebrovascular disease |
| CN1586544A (en) * | 2004-07-14 | 2005-03-02 | 张国强 | Medicinal wine and its producing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101537121A (en) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN101554470A (en) | Traditional Chinese medicine for treating tachycardia | |
| CN101537114B (en) | Chinese medicine for treating arrhythmia | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101554445B (en) | Traditional Chinese medicine for treating diabetic hyperlipemia | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101537068B (en) | Chinese medicine for treating angina | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101554412B (en) | Traditional Chinese medicine for treating atrial fibrillation | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101530501B (en) | Traditional Chinese medicine for treating diabetic anemia | |
| CN101554441A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101518622B (en) | Traditional Chinese medicine for treating diabetes complicated with urinary infection | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101554434B (en) | Traditional Chinese medicine for treating clinical hypertension | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101850078A (en) | Chinese medicament for treating chronic nephritis | |
| CN102091222A (en) | Traditional Chinese medicine for treating diabetic peripheral neuropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO GRINDING HEAD CONSTRUCTION DEVELOPMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: 226500 Guangming West Road, grinding head town, Rugao, Jiangsu Patentee after: Rugao grinding head Construction Development Co Ltd Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602 Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20190319 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |